Squarepoint Ops LLC Infinity Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $81,032 - $228,796	-95,332 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $78,999 - $142,709	42,473 Added 80.35%	95,332 $214,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $70,310 - $176,701	-46,257 Reduced 46.67%	52,859 $181,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $263,648 - $343,932	99,116 New	99,116 $296,000
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $42,408 - $64,554	-23,560 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $112,484 - $343,906	-92,200 Reduced 79.65%	23,560 $48,000
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $108,814 - $156,276	115,760	115,760 $154,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.